Connect with us
Sarcomas are rare malignant tumors of connective tissue, representing a small cancer percentage but posing major treatment challenges. Advanced biotechnology, especially CAR-T immunotherapies, offers hope. CIBERONC...
Spain’s Ministry of Science has awarded €126.9M in subsidies to companies in the EU-backed IPCEI Med4Cure project. The initiative supports healthcare innovation, advanced therapies, and sustainable...
The €196.4 million Biotech Booster fund in the Netherlands supports scientists and research teams to turn biotech innovations into market-ready solutions. Funded by the National Growth...
Ecnoglutide, a once-weekly GLP-1 receptor agonist, showed up to 13.2% weight loss over 40 weeks in obese or overweight adults without diabetes in a Phase III...
Vytrus Biotech’s 2024 Sustainability Report highlights major progress in plant stem cell innovation, resource savings, and ESG efforts. Key achievements include award-winning product Baolift™, strong certifications,...
Pfizer Spain’s 2024 Impact Report highlights its leadership in clinical research, €54M R&D investment, four new treatments, and 113 trials across 13 areas. Marking Pfizer’s 175th...
Obesity, diabetes, and cardiovascular disease are increasingly common in the population. Brown adipose tissue plays a protective role against these prevalent diseases, as it burns calories...
In 2024, Europe and Spain advanced strategic biotechnology legislation, reinforcing biotech as key to economic growth and autonomy. Spain’s biotech sector grew, generating €13B in revenue...
Galicia has approved a €15.6 million investment to supply gene therapy for hemophilia B, becoming the first region in Spain to do so. The therapy, Etranacogene...
A BioSim study highlights biosimilars’ crucial role in reducing Spain’s healthcare spending, projecting €22.27 billion in savings from 2024–2030. Despite rising biologic drug costs, biosimilars ensure...